FMP
AMEX
0.0355 USD
-0.0006 (-1.69%)
Mr. Craig A. Dais CPA
Healthcare
Biotechnology
https://www.navidea.com
AMEX
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates through two segments, Diagnostic Substances and Therapeutic Development Programs. The company develops Manocept platform to target the CD206 mannose receptor expressed on activated macrophages for a range of diagnostic modalities, including single photon emission computed tomography, positron emission tomography (PET), gamma-scanning, and intra-operative and/or optical-fluorescence detection, as well as delivery of therapeutic compounds that target macrophages, and immune-and inflammation-involved diseases. It...
0000810509
US63937X2027
63937X202
4995 Bradenton Avenue
614 793 7500
US
11
Nov 10, 1992
0000810509
AMEX
Biotechnology
Healthcare
63937X202
US63937X2027
US
0.04
1.13
116.09k
3.55M
-
0.021-0.32955
-0.02
-
-
-
-
-0.18
-
https://www.navidea.com
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.